What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001582384
Total reported value
$228.5M
$228.5M
16 檔
71.5%
As reported in its official Q1 2024 Form 13F filing, Wildcat Capital Management, LLC's tracked investment portfolio stood at $228.5M with 16 total positions.
In Q1 2024, Wildcat Capital Management, LLC adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 5 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FYBR | Frontier Communications Pare | Stock-Other | 12.48% | — | — | |
| 2 | GSHD | Goosehead Insurance Inc -a | Stock-Other | 12.48% | — | — | |
| 3 | MCO | Moody's CORP | Stock-Financials | 11.73% | — | +43.70% | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 11.45% | — | — | |
| 5 | RLX | Rlx Technology Inc-adr | Stock-Other | 11.15% | — | — | |
| 6 | GLBE | Global-E Online Ltd. | Stock-Other | 10.57% | — | — | |
| 7 | DASH | Doordash Inc - A | Stock-Consumer Disc | 8.75% | — | — | |
| 8 | META | Meta Platforms Inc-class A | Stock-Comm Services | 8.60% | — | -31.07% | |
| 9 | ALLO | Allogene Therapeutics Inc | Stock-Other | 2.86% | -4.05% | — | |
| 10 | URGN | UroGen Pharma Ltd. | Stock-Other | 2.70% | — | — | |
| 11 | CNSLEUR | Consolidated Communications | Stock-Other | 2.34% | — | -50.24% | |
| 12 | ✓ | Skillz Inc | Stock-Other | 2.31% | — | — | |
| 13 | COIN | Coinbase Global Inc -class A | Stock-Financials | 1.65% | — | — | |
| 14 | KRON1USD | Kronos Bio Inc | Stock-Other | 0.61% | — | — | |
| 15 | NMRA | Neumora Therapeutics Inc | Stock-Other | 0.27% | — | — | |
| 16 | ✓ | Akili, Inc. | Stock-Other | 0.06% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MCO | Moody's CORP | +4% | +43.70% | Add |
| 2 | MSFT | Microsoft CORP | +1.7% | — | Unchanged |
| 3 | ALLO | Allogene Therapeutics Inc | +0.7% | — | Unchanged |
| 4 | COIN | Coinbase Global Inc -class A | +0.6% | — | Unchanged |
| 5 | DASH | Doordash Inc - A | +0.4% | — | Unchanged |
| 6 | NMRA | Neumora Therapeutics Inc | +0.3% | NEW | New buy |
| 7 | ✓ | Skillz Inc | +0.2% | — | Unchanged |
| 8 | URGN | UroGen Pharma Ltd. | +0.1% | — | Unchanged |
| 9 | FYBR | Frontier Communications Pare | +0.1% | — | Unchanged |
| 10 | KRON1USD | Kronos Bio Inc | +0.1% | — | Unchanged |
| 11 | ✓ | Akili, Inc. | 0% | — | Unchanged |
| 12 | NRDY | Nerdy Inc | 0% | EXIT | Sold out |
| 13 | BRZE | Braze Inc-a | 0% | EXIT | Sold out |
| 14 | META | Meta Platforms Inc-class A | -0.1% | -31.07% | Trim |
| 15 | DDOG | Datadog Inc - Class A | -0.1% | EXIT | Sold out |
| 16 | PRAX | Praxis Precision Medicines I | -0.1% | EXIT | Sold out |
| 17 | GLBE | Global-E Online Ltd. | -0.4% | — | Unchanged |
| 18 | GSHD | Goosehead Insurance Inc -a | -1% | — | Unchanged |
| 19 | RLX | Rlx Technology Inc-adr | -1.3% | — | Unchanged |
| 20 | CNSLEUR | Consolidated Communications | -2.2% | -50.24% | Trim |
| 21 | TOST | Toast Inc-class A | -2.8% | EXIT | Sold out |
According to official SEC Form 13F filings, Wildcat Capital Management, LLC reported a total U.S. public equity portfolio value of $228.5M across 16 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including FYBR, GSHD, MCO) accounted for 71.5% of total reported equity market value during Q1 2024.
Top New Position Initiated
NMRA
市值: $754.8K
Top Position Liquidated / Trimmed
TOST
前期市值: $8.1M
During Q1 2024, Wildcat Capital Management, LLC's top holdings by market value included FYBR (12.5%)、GSHD (12.5%)、MCO (11.7%). The largest single position, FYBR, represented 12.5% of total portfolio value.
In Q1 2024, Wildcat Capital Management, LLC made 9 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.